NVCR profile · all as-reported value updates
NovoCure Ltd (NVCR) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Capital expenditures | 2017 | 2,459,000 | 7,366,000 | 4,907,000 | +66.62% | revised comparative figure | 0001564590-18-002766 0001645113-20-000025 | 3 filed observations examined for this concept and period. |
| Capital expenditures | 2018 | 2,916,000 | 6,711,000 | 3,795,000 | +56.55% | revised comparative figure | 0001564590-19-005146 0001645113-21-000017 | 3 filed observations examined for this concept and period. |